Irinotecan Safety Reports submitted to FDA
>>>Help Community - Review Your Irinotecan Side Effect Episode
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZTotal Irinotecan reports: 266.
Irinotecan FDA safety alerts: 2002 .
Reported deaths: 67 Reported hospitalizations: 169.
Take Irinotecan Side Effects Survey, Discuss Irinotecan with others or
Add Your Side Effect to the Community Database
FDA Reported Irinotecan Side Effects: diarrhoea, vomiting, nausea, neutropenia, interstitial lung disease, pyrexia, leukopenia, loss of consciousness, asthenia, thrombocytopenia, dehydration.
More About Irinotecan.
If you have questions about Irinotecan, you can ask a Health Expert or Ask Patient Community about Irinotecan.
Showing 1-100 of 266 Next >
Irinotecan Side Effects Report #5088871-XHealth Professional from UNITED STATES reported IRINOTECAN problem on Aug 25, 2006. Male patient, 69 years of age, weighting 141.0 lb, was diagnosed with neoplasm malignant and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: pneumonia. IRINOTECAN dosage: 50 MG/M2 D1,8,22,29 Q 6 WKS IV. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5089562-1
IRINOTECAN problem was reported by a Physician from UNITED STATES on Aug 10, 2006. Male patient, 53 years of age, weighting 167.0 lb, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome. IRINOTECAN dosage: 150 MG/M2 (1 IN 3 WK), INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, NEULASTA, DEXAMETHASONE, ONDANSETRON, LORTAB, PROMETHAZINE. Patient died on 06/28/2006.
Irinotecan Side Effects Report #5091890-0
Health Professional from JAPAN reported IRINOTECAN problem on Aug 08, 2006. Female patient, 71 years of age, was diagnosed with ovarian cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. IRINOTECAN dosage: unknown. Patient recovered.
Irinotecan Side Effects Report #5093808-3
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2006. Male patient, weighting 227.1 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: diplopia, headache, hydrocephalus, implant site haemorrhage, nausea, vith nerve paralysis, vomiting. IRINOTECAN dosage: 125MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, LOTREL, NEXIUM, DECADRON, GLUCOTROL, CALCIUM PLUS, VITAMIN D, ZOFRAN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5093813-7
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Aug 29, 2006. Female patient, weighting 127.2 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: pneumothorax, procedural complication. IRINOTECAN dosage: 125MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5094325-7
IRINOTECAN problem was reported by a Health Professional from UNITED STATES on Aug 30, 2006. Female patient, weighting 114.6 lb, was diagnosed with oesophageal carcinoma and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, dehydration, fatigue, incontinence, leukopenia, malnutrition, nausea, neutrophil count abnormal. IRINOTECAN dosage: unknown. During the same period patient was treated with CISPLATIN, CETUXIMAB, MIRALAX, FOSAMAX, ATIVAN, CLINDAGEL, CLONAZEPAM. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5096737-4
Physician from JAPAN reported IRINOTECAN problem on June 30, 2006. Male patient, 78 years of age, weighting 131.0 lb, was diagnosed with lung neoplasm malignant and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qrs complex prolonged, flushing, heart rate increased, hypoxia, infection, interstitial lung disease, leukopenia, loss of consciousness, lymphangiosis carcinomatosa. IRINOTECAN dosage: 95 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with DECADRON, KYTRIL. Patient died on 06/29/2006.
Irinotecan Side Effects Report #5096805-7
IRINOTECAN problem was reported by a Physician from JAPAN on Aug 11, 2006. Female patient, 70 years of age, weighting 89.29 lb, was diagnosed with ovarian cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, heart rate abnormal, hypokalaemia, loss of consciousness, syncope vasovagal, urinary incontinence. IRINOTECAN dosage: unknown. During the same period patient was treated with NORVASC. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5123553-7
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Oct 12, 2005. Male patient, 47 years of age, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: carcinoembryonic antigen increased, thrombosis, weight increased. IRINOTECAN dosage: unknown. During the same period patient was treated with LEUCOVORIN ACID, FLUOROURACIL. Patient recovered.
Irinotecan Side Effects Report #5096876-8
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 01, 2006. Male patient, weighting 227.1 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: csf pressure increased, diplopia, headache, hydrocephalus, nausea, post procedural haemorrhage, vith nerve paralysis, vomiting. IRINOTECAN dosage: 125MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, LOTREL, NEXIUM, DECADRON, GLUCOTROL, CALCIUM PLUS VITAMIN D, ZOFRAN, INNOHEP. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5097538-3
Physician from JAPAN reported IRINOTECAN problem on Aug 09, 2006. Male patient, 67 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. IRINOTECAN dosage: 171 MG, SINGLE. During the same period patient was treated with ZOFRAN, DECADRON, PRIMPERAN, CLONAZEPAM, MUCOSTA, DEPAS, MAGNESIUM OXIDE, SALICYLAMIDE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5099781-6
IRINOTECAN problem was reported by a Physician from JAPAN on Aug 10, 2006. Male patient, 67 years of age, weighting 138.5 lb, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: cell marker increased, interstitial lung disease, pneumonia fungal. IRINOTECAN dosage: unknown. During the same period patient was treated with TEGAFUR, NORVASC. Patient recovered.
Irinotecan Side Effects Report #5100592-3
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Sept 07, 2006. Male patient, weighting 200.0 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea. IRINOTECAN dosage: 325 MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DILANTIN, LEXAPRO, PHRENILIN, OXYCODONE, DEXAMETHASONE, KEPPRA. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5102661-0
IRINOTECAN problem was reported by a Health Professional from JAPAN on Aug 25, 2006. Female patient, 71 years of age, was diagnosed with ovarian cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: myelodysplastic syndrome. IRINOTECAN dosage: unknown. Patient recovered.
Irinotecan Side Effects Report #5107515-1
Health Professional from UNITED STATES reported IRINOTECAN problem on Sept 13, 2006. Male patient, 69 years of age, weighting 141.0 lb, was diagnosed with neoplasm malignant and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: dysphasia, malignant neoplasm progression, performance status decreased, pneumonia aspiration. IRINOTECAN dosage: 50 MG/M2 D1,8,22,29 Q 6WKS IV. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5107719-8
IRINOTECAN problem was reported by a Physician from JAPAN on Aug 25, 2006. Male patient, 74 years of age, weighting 126.1 lb, was diagnosed with pleural mesothelioma malignant and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, lymphocyte stimulation test positive, pyrexia, respiratory failure. IRINOTECAN dosage: 60 MG (1 IN 7 D), INTRAVENOUS. During the same period patient was treated with METHOTREXATE, DOXORUBICIN. Patient recovered.
Irinotecan Side Effects Report #5108031-3
Physician from JAPAN reported IRINOTECAN problem on Sept 01, 2006. Female patient, 61 years of age, weighting 97.00 lb, was diagnosed with gastric cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, ill-defined disorder, leukopenia, malignant neoplasm progression, metastases to peritoneum, neutropenia. IRINOTECAN dosage: 66.7 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient recovered.
Irinotecan Side Effects Report #5113747-9
IRINOTECAN problem was reported by a Health Professional from FRANCE on Dec 24, 1991. Female patient, 53 years of age, was diagnosed with laryngeal cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, septic shock. IRINOTECAN dosage: unknown. During the same period patient was treated with DICLOFENAC, MORPHINE. Patient died on 12/23/1991.
Irinotecan Side Effects Report #5115028-6
Physician from UNITED STATES reported IRINOTECAN problem on Sept 25, 2006. Female patient, 65 years of age, weighting 189.0 lb, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: clostridial infection, febrile neutropenia, neutrophil count increased, rebound effect, white blood cell count increased. IRINOTECAN dosage: 150 MG/M2 Q3W IV. During the same period patient was treated with OXALIPLATIN, NEULASTA, AVANDIA, GLIPIZIDE ER, ACIPHEX, ENALAPRIL MALEATE, BUSPIRONE, FLUOXETINE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5115397-7
IRINOTECAN problem was reported by a Health Professional from FRANCE on Nov 26, 1992. Male patient, 68 years of age, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: no adverse effect. IRINOTECAN dosage: 612 MG (1 IN 3 WK), INTRAVENOUS. During the same period patient was treated with CYPROHEPTADINE, VITAMINS WITH MINERALS, MORPHINE, PHLOROGLUCINOL, THEODRENALINE. Patient recovered.
Irinotecan Side Effects Report #5115438-7
Physician from FRANCE reported IRINOTECAN problem on Sept 12, 2006. Female patient, 54 years of age, weighting 130.1 lb, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, renal failure acute. IRINOTECAN dosage: 150 MG (150 MG,1 IN 1 D), INTRAVENOUS. During the same period patient was treated with LEUCOVORIN CALCIUM, ONDANSETRON, AVASTIN, ATROPINE SULPHATE, FLUOROURACIL. Patient was hospitalized. Patient died.
Irinotecan Side Effects Report #5117075-7
IRINOTECAN problem was reported by a Health Professional from JAPAN on Sept 11, 2006. Female patient, 71 years of age, was diagnosed with ovarian cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: cellulitis, marrow hyperplasia, myelodysplastic syndrome, rectal neoplasm, refractory anaemia with an excess of blasts, thrombocytopenia, vaginal haemorrhage. IRINOTECAN dosage: unknown. Patient recovered.
Irinotecan Side Effects Report #5117253-7
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Sept 27, 2006. Male patient, weighting 200.0 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, diarrhoea, haemoglobin decreased, hyponatraemia, neutropenia. IRINOTECAN dosage: 325 MG /M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DILANTIN, LEXAPRO, PHREMILIN, OXYCODONE, DEXAMETHASONE, KEPPRA, ZANTAC. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5117839-X
IRINOTECAN problem was reported by a Physician from JAPAN on Sept 14, 2006. Female patient, 61 years of age, weighting 97.00 lb, was diagnosed with gastric cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, leukopenia, malignant neoplasm progression, neutropenia, peritoneal carcinoma. IRINOTECAN dosage: 66.7 MG/M2, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient recovered.
Irinotecan Side Effects Report #5117954-0
Physician from JAPAN reported IRINOTECAN problem on Sept 13, 2006. Female patient, 67 years of age, weighting 81.57 lb, was diagnosed with ovarian cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: anorexia, bone marrow failure, condition aggravated, infection, interstitial lung disease, malaise, malnutrition, metastases to spleen. IRINOTECAN dosage: unknown. During the same period patient was treated with NEUPOGEN, ETOPOSIDE, TAXOTERE. Patient was hospitalized. Patient died on 03/03/2005.
Irinotecan Side Effects Report #5118728-7
IRINOTECAN problem was reported by a Physician from JAPAN on Sept 13, 2006. Male patient, 57 years of age, was diagnosed with lung adenocarcinoma and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, glomerulonephritis membranous, nephrotic syndrome, pleural effusion. IRINOTECAN dosage: unknown. During the same period patient was treated with PACLITAXEL, IRESSA. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5121906-4
Health Professional from UNITED STATES reported IRINOTECAN problem on Nov 30, 2005. Female patient, 66 years of age, was diagnosed with colorectal cancer metastatic, diarrhoea, arthralgia, pain in extremity, nausea and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: nausea, vomiting. IRINOTECAN dosage: unknown. During the same period patient was treated with IMODIUM, DARVOCET, KYTRIL. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5121966-0
IRINOTECAN problem was reported by a Physician from ITALY on Sept 20, 2006. Female patient, 66 years of age, weighting 134.5 lb, was diagnosed with non-small cell lung cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: asthenia, confusional state, dyspnoea, metastases to bone, metastases to liver, neuropathy, neurotoxicity, neutrophil percentage increased, pericardial effusion. IRINOTECAN dosage: 90 MG (D1, D8, D15, D22 EVERY SIX WEEKS), INTRAVENOUS. During the same period patient was treated with DOCETAXEL, ALLOPURINOL, CALCIUM, OMEPRAZEN, DELTACORTENE, TRANEX, AMINOMAL ELISIR. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5125992-7
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Oct 10, 2006. Male patient, weighting 161.6 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, pneumocystis jiroveci pneumonia, pyrexia. IRINOTECAN dosage: 125MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DECADRON, ZANTAC, FLORINEF. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5126325-2
IRINOTECAN problem was reported by a Physician from UNITED STATES on Sept 25, 2006. Male patient, 53 years of age, weighting 167.0 lb, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome. IRINOTECAN dosage: 150 MG/M1 (1 IN 3 WK), INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, NEULASTA, DEXAMETHASONE, ONDANSETRON, LORTAB, PROMETHAZINE. Patient died on 06/28/2006.
Irinotecan Side Effects Report #5127462-9
Physician from JAPAN reported IRINOTECAN problem on Sept 27, 2006. Female patient, 67 years of age, was diagnosed with colon cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood creatinine increased, condition aggravated, diarrhoea, dyspnoea, haemoglobin decreased, hepatorenal failure, hyperthermia. IRINOTECAN dosage: 160 MG, INTRAVENOUS (SEE IMAGE). Patient was hospitalized. Patient died on 05/18/2004.
Irinotecan Side Effects Report #5127467-8
IRINOTECAN problem was reported by a Health Professional from UNITED STATES on Oct 13, 2006. Male patient, weighting 211.4 lb, was diagnosed with oligodendroglioma and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time abnormal, deep vein thrombosis, embolism, prothrombin time abnormal. IRINOTECAN dosage: 274MG IV (DAY 1,8,22 AND 29). During the same period patient was treated with BEVACIZUMAB, KEPPRA, AMBIEN, FLOMAX, SENOKOT. Patient recovered.
Irinotecan Side Effects Report #5128742-3
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Sept 29, 2006. Male patient, weighting 240.0 lb, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: fatigue, haemoglobin decreased, insomnia, red blood cell count decreased, unevaluable event. IRINOTECAN dosage: 150 MG (150 MG). During the same period patient was treated with ATROPINE, ALLOPURINOL, ASPIRIN, PLAVIX, TRIAMTERENE, SIMVASTATIN, INSULIN. Patient recovered.
Irinotecan Side Effects Report #5130665-0
IRINOTECAN problem was reported by a Health Professional from UNITED STATES on Oct 18, 2006. Female patient, weighting 177.3 lb, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, anorexia, constipation, cytomegalovirus infection, nausea, vomiting. IRINOTECAN dosage: unknown. During the same period patient was treated with CELEBREX, OXYCONTIN, COMPAZINE, KYTRIL, SENNA, COLACE, REGLAN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5130667-4
Health Professional from UNITED STATES reported IRINOTECAN problem on Oct 18, 2006. Male patient, weighting 201.0 lb, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: small intestinal obstruction. IRINOTECAN dosage: unknown. During the same period patient was treated with CELEBREX, EFFEXOR, PROTONIX, ULTRAM, ZOFRAN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5132948-7
IRINOTECAN problem was reported by a Health Professional from UNITED STATES on Oct 19, 2006. Male patient, weighting 162.0 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: convulsion, hemiparesis. IRINOTECAN dosage: 644 MG IV (DAY 1, 8, 22 AND 29). During the same period patient was treated with BEVACIZUMAB, DILANTIN, PROTONIX, GLUCOPHAGE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5133094-9
Physician from JAPAN reported IRINOTECAN problem on Oct 04, 2006. Female patient, 56 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, inappropriate antidiuretic hormone secretion, loss of consciousness, vomiting. IRINOTECAN dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5133778-2
IRINOTECAN problem was reported by a Health Professional from JAPAN on May 19, 1999. Male patient, 69 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, contraindication to medical treatment, depressed level of consciousness, grand mal convulsion, hepatic failure, hypokalaemia, leukopenia, malignant neoplasm progression, metastases to liver. IRINOTECAN dosage: 100 MG/M*2, INTRAVENOUS. During the same period patient was treated with AMINO ACIDS, CEFOZOPRAN HYDROCHLORIDE, CLINDAMYCIN PHOSPHATE, HANGE, LENORGRASTIM, METOCLOPRAMIDE, PHENYTOIN, VALPROATE. Patient died on 04/04/1999.
Irinotecan Side Effects Report #5133990-2
Health Professional from UNITED STATES reported IRINOTECAN problem on Oct 23, 2006. Male patient, 73 years of age, weighting 146.2 lb, was diagnosed with non-small cell lung cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, neutropenia. IRINOTECAN dosage: 700 MG Q 3 WKS IV. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5136854-3
IRINOTECAN problem was reported by a Health Professional from FRANCE on Oct 11, 2006. Female patient, 33 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, hyperthermia, influenza like illness. IRINOTECAN dosage: 320 MG, INTRAVENOUS. During the same period patient was treated with KYTRIL, FLUOROURACIL, GRANISETRON HYDROCHLORIDE, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5140955-3
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Oct 27, 2006. Female patient, weighting 116.4 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: glioblastoma multiforme, haematocrit decreased, haemoglobin abnormal, postoperative abscess, pyrexia. IRINOTECAN dosage: 325MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DILANTIN, NEXIUM, DEXAMETHASONE, SENOKOT, ENDOCET. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5143214-8
IRINOTECAN problem was reported by a Health Professional from JAPAN on Oct 16, 2006. Male patient, 64 years of age, was diagnosed with ill-defined disorder and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, interstitial lung disease, leukopenia, neutropenia. IRINOTECAN dosage: (100 MG), INTRAVENOUS. During the same period patient was treated with NEDAPLATIN. Patient recovered.
Irinotecan Side Effects Report #5144806-2
Health Professional from UNITED STATES reported IRINOTECAN problem on Nov 03, 2006. Male patient, 63 years of age, weighting 173.0 lb, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, bacteraemia, blood pressure increased, bowel sounds abnormal, catheter related infection, dehydration, faecaloma, intestinal functional disorder, intestinal obstruction. IRINOTECAN dosage: 150MG/M2 Q 2 WKS IV. During the same period patient was treated with CETUXIMAB, FLUOXETINE, ASPIRIN, ZYPREXA, COMPAZINE, SENOKOT, IMODIUM, DOXYCYCLINE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5146412-2
IRINOTECAN problem was reported by a Physician from UNITED STATES on Oct 23, 2006. Male patient, 52 years of age, was diagnosed with colon cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: homicide, metabolic encephalopathy, neoplasm, psychotic disorder. IRINOTECAN dosage: unknown. Patient recovered.
Irinotecan Side Effects Report #5146833-8
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Nov 07, 2006. Male patient, weighting 161.6 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: anaemia, arrhythmia, cardiac disorder, central nervous system infection, ejection fraction decreased, hypoalbuminaemia, hypotension, immunosuppression, loss of consciousness. IRINOTECAN dosage: 125MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DECADRON, ZANTAC, FLORINEF. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5146834-X
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2006. Female patient, weighting 127.2 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: collapse of lung, confusional state, haematotoxicity, haemoglobin abnormal, hyperglycaemia, hypoalbuminaemia, hypocalcaemia, hypokalaemia, hyponatraemia. IRINOTECAN dosage: 125MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, METOPROLOL, TIMOLOL MALEATE, DECADRON, ACTONEL, PRILOSEC, VALTREX, DIFLUCAN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5148077-2
Physician from JAPAN reported IRINOTECAN problem on Oct 24, 2006. Female patient, 80 years of age, was diagnosed with rectal cancer recurrent and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, disseminated intravascular coagulation, pancytopenia, pneumonia, respiratory disorder, staphylococcal infection. IRINOTECAN dosage: 140 MG (1 IN 1 WK), INTRAVENOUS. During the same period patient was treated with LEUCOVORIN CALCIUM. Patient died on 11/15/2005.
Irinotecan Side Effects Report #5150732-5
IRINOTECAN problem was reported by a Consumer or non-health professional from FRANCE on Feb 04, 1998. Male patient, 44 years of age, was diagnosed with metastasis, colorectal cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, asthenia, malaise, pain in jaw, pulmonary embolism. IRINOTECAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID. Patient died on 01/19/1998.
Irinotecan Side Effects Report #5150864-1
Health Professional from HUNGARY reported IRINOTECAN problem on Nov 15, 2001. Male patient, 70 years of age, was diagnosed with gastric cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: asthenia, cholecystitis acute, cholelithiasis, nausea, pyrexia. IRINOTECAN dosage: 110 MG, CYCLICALLY, INTRAVENOUS. During the same period patient was treated with LEUCOVORIN CALCIUM, FLUOROURACIL, ENSURE PLUS, FERROGRAD, VALIUM. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5150868-9
IRINOTECAN problem was reported by a Consumer or non-health professional from FRANCE on Oct 03, 1996. Male patient, 61 years of age, was diagnosed with colorectal cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, anaemia, blood creatinine decreased, blood potassium decreased, blood sodium decreased, international normalised ratio decreased, phlebitis, red blood cell sedimentation rate increased. IRINOTECAN dosage: 150 MG/M*2 (CYCLICALLY), INTRAVENOUS. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5150871-9
Consumer or non-health professional from FRANCE reported IRINOTECAN problem on Oct 01, 1999. Female patient, 49 years of age, was diagnosed with lung cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: phlebitis deep. IRINOTECAN dosage: 210 MG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, OXALIPLATIN, MAXILASE, DAFLON. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5152122-8
IRINOTECAN problem was reported by a Health Professional from UNITED STATES on Nov 13, 2006. Male patient, 63 years of age, weighting 173.0 lb, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: bacteraemia, blood culture positive, blood pressure increased, central line infection, dehydration, ileus, intestinal obstruction, klebsiella infection, rash. IRINOTECAN dosage: 150MG/M2 Q 2 WKS IV. During the same period patient was treated with CETUXIMAB, FLUXETINE, ASPIRIN, ZYPREXA, COMPAZINE, SENOKOT, IMODIUM, DOXYCYCLINE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5152578-0
Consumer or non-health professional from ITALY reported IRINOTECAN problem on May 15, 2002. Female patient, 65 years of age, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: cachexia, coma, cyanosis, diarrhoea, loss of consciousness, mucosal inflammation, neutropenia, pulmonary embolism, pulse absent. IRINOTECAN dosage: 280 MG (ONCE), INTRAVENOUS; SEE IMAGE. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, FOLINIC ACID, BACITRACINE, FLUCONAZOLE. Patient died on 05/14/2002.
Irinotecan Side Effects Report #5152581-0
IRINOTECAN problem was reported by a Health Professional from FRANCE on Mar 03, 1997. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: biliary dilatation, cholestasis, neoplasm progression. IRINOTECAN dosage: 460 MG, INTRAVENOUS. During the same period patient was treated with AMLODIPINE, ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, MOSCONTIN, OXALIPLATIN, VISCERALGINE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5152586-X
Consumer or non-health professional from FRANCE reported IRINOTECAN problem on Feb 24, 1995. Male patient, 59 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: bronchospasm, bundle branch block left, cardiovascular disorder, haemoglobin decreased, hyponatraemia, platelet count increased, pneumothorax, tachycardia. IRINOTECAN dosage: 520 MG (EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with AMIODARONE, DESLANOSIDE, DIGOXIN. Patient was hospitalized. Patient died on 02/25/1995.
Irinotecan Side Effects Report #5152588-3
IRINOTECAN problem was reported by a Consumer or non-health professional from FRANCE on Nov 09, 1993. Female patient, 62 years of age, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, cardiogenic shock, cerebral haemorrhage, colon cancer, convulsion, depressed level of consciousness, gastrointestinal haemorrhage. IRINOTECAN dosage: 560 MG (1 IN 3 WK), INTRAVENOUS. During the same period patient was treated with ENALAPRIL MALEATE, MORPHINE, OXAZEPAM, PREDNISOLONE, RANITIDINE. Patient was hospitalized. Patient died on 10/18/1993.
Irinotecan Side Effects Report #5154479-0
Health Professional from FRANCE reported IRINOTECAN problem on Nov 13, 2006. Male patient, 43 years of age, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, lung disorder, neoplasm progression, pericardial effusion, pericarditis, viral infection. IRINOTECAN dosage: unknown. During the same period patient was treated with ACENOCOUMAROL, ACETORPHAN, AMOXICILLIN, MORPHINE, OFLOXACIN, PYRIDOSTIGMINE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5154480-7
IRINOTECAN problem was reported by a Health Professional from FRANCE on May 05, 1992. Male patient, 63 years of age, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: anaemia, aplasia, blood creatinine increased, blood potassium increased, dehydration, diarrhoea, gastrointestinal haemorrhage, nausea, pancytopenia. IRINOTECAN dosage: (115 MG/M*2, EVERY WEEK), INTRAVENOUS. During the same period patient was treated with ATROPINE, PLASMION. Patient died on 02/25/1992.
Irinotecan Side Effects Report #5154507-2
Consumer or non-health professional from FRANCE reported IRINOTECAN problem on May 10, 1993. Male patient, 66 years of age, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: anti-platelet antibody positive, bacterial infection, cardiogenic shock, central line infection, dehydration, diarrhoea, dyspnoea, escherichia infection. IRINOTECAN dosage: 600 MG/M*2 (EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, GINKO BILOBA. Patient was hospitalized. Patient died on 05/16/1993.
Irinotecan Side Effects Report #5154508-4
IRINOTECAN problem was reported by a Physician from GERMANY on Dec 17, 1998. Male patient, 63 years of age, was diagnosed with colorectal cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: circulatory collapse, ill-defined disorder, loss of consciousness. IRINOTECAN dosage: 350 MG, INTRAVENOUS. During the same period patient was treated with AMINOPHYLLIN, BUDESONIDE, LOPERAMIDE, TERBUTALINE SULPHATE. Patient was hospitalized. Patient died on 12/28/1998.
Irinotecan Side Effects Report #5154509-6
Physician from FRANCE reported IRINOTECAN problem on Feb 02, 1998. Male patient, 13 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, disease progression, dyspnoea at rest, electrocardiogram abnormal, hepatomegaly, mitral valve incompetence, oedema peripheral, pericardial effusion, tricuspid valve incompetence. IRINOTECAN dosage: 600 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5154510-2
IRINOTECAN problem was reported by a Physician from NETHERLANDS on July 07, 1995. Female patient, 37 years of age, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: anal haemorrhage, haematemesis, haemoglobin decreased, hypotension, nausea, platelet count decreased, vomiting, white blood cell count decreased. IRINOTECAN dosage: 520 MG, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5154527-8
Consumer or non-health professional from GERMANY reported IRINOTECAN problem on Feb 10, 1998. Male patient, 59 years of age, was diagnosed with colorectal cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: anorexia, back pain, cardiac disorder, constipation, fatigue, hyperhidrosis, hypertension, peripheral coldness. IRINOTECAN dosage: 350 MG/M*2 (EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with PROSTAGUTT. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5154528-X
IRINOTECAN problem was reported by a Consumer or non-health professional from GERMANY on Jan 19, 1998. Male patient, 69 years of age, was diagnosed with colorectal cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, cheilitis, diarrhoea, dyspnoea, fall, gastroenteritis bacterial, gastroenteritis staphylococcal, haematemesis, nausea. IRINOTECAN dosage: 750 MG (EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with TROPISETRON. Patient was hospitalized. Patient died on 01/16/1998.
Irinotecan Side Effects Report #5154529-1
Consumer or non-health professional from GERMANY reported IRINOTECAN problem on Aug 14, 1998. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: back pain, cardiac failure, diarrhoea. IRINOTECAN dosage: 133 MG, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 03/07/1998.
Irinotecan Side Effects Report #5154626-0
IRINOTECAN problem was reported by a Physician from GERMANY on Mar 28, 1998. Male patient, 67 years of age, was diagnosed with rectal cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, leukopenia, malignant neoplasm progression, rectal cancer metastatic, sepsis, thrombocytopenia. IRINOTECAN dosage: 530 MG, INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, DEXABENE, ZANTIC, ZOFRAN. Patient died on 03/25/1998.
Irinotecan Side Effects Report #5154627-2
Consumer or non-health professional from FRANCE reported IRINOTECAN problem on Aug 04, 1999. Female patient, 46 years of age, was diagnosed with colorectal cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: anaemia, diarrhoea, intestinal obstruction, intestinal perforation, mesenteric vascular insufficiency, multi-organ failure, peritoneal carcinoma, peritonitis, shock. IRINOTECAN dosage: 300 MG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, OXALIPLATIN, DAFALGAN, POTASSIUM ACETATE, LEXOMIL. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5154629-6
IRINOTECAN problem was reported by a Health Professional from NETHERLANDS on Dec 16, 2003. Male patient, 58 years of age, was diagnosed with colorectal cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: sepsis, skin infection. IRINOTECAN dosage: 480 MG ONCE, INTRAVENOUS. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 11/22/2003.
Irinotecan Side Effects Report #5156708-6
Physician from UNITED STATES reported IRINOTECAN problem on Nov 03, 2006. Male patient, 74 years of age, was diagnosed with colorectal cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: anorexia, apnoea, diarrhoea, febrile neutropenia, gastrointestinal toxicity, haematocrit decreased, haemoglobin decreased, lymphocyte percentage decreased, monocyte count increased. IRINOTECAN dosage: 742 MG (CYCLICAL), INTRAVENOUS. During the same period patient was treated with CETUXIMAB, ASPIRIN, IBUPROFEN, METFORMIN, OLMESARTAN MEDOXOMIL, TEMAZEPAM, SULFISOXAZOLE. Patient was hospitalized. Patient died on 11/28/2004.
Irinotecan Side Effects Report #5158756-9
IRINOTECAN problem was reported by a Physician from JAPAN on Oct 31, 2006. Female patient, 74 years of age, weighting 88.18 lb, was diagnosed with pancreatic carcinoma, pain and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: malaise, nausea, vomiting. IRINOTECAN dosage: 50 MG (50 MG, 1 IN 2 WK), INTRAVENOUS. During the same period patient was treated with MORPHINE SULPHATE, OXALIPLATIN, LASIX, ALDACTONE, RABEPRAZOLE, KRESTIN, URSO. Patient recovered.
Irinotecan Side Effects Report #5159471-8
Health Professional from UNITED STATES reported IRINOTECAN problem on Nov 22, 2006. Male patient, 63 years of age, weighting 173.0 lb, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, bowel sounds abnormal, faecaloma, ileus, intestinal functional disorder, klebsiella infection, obstruction, rash, respiratory rate increased. IRINOTECAN dosage: 150MG/M2 Q 2 WKS IV. During the same period patient was treated with CETUXIMAB, FLUXETINE, ASPIRIN, ZYPREXA, COMPEZINE, SENOKOT, IMODIUM, DOXYCYCLINE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5160554-7
IRINOTECAN problem was reported by a Physician from UNITED STATES on Nov 08, 2006. Male patient, 79 years of age, was diagnosed with gastric cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, autonomic neuropathy, gastrointestinal haemorrhage, orthostatic hypotension. IRINOTECAN dosage: unknown. Patient died on 11/08/2005.
Irinotecan Side Effects Report #5165257-0
Health Professional from UNITED KINGDOM reported IRINOTECAN problem on Nov 13, 2006. Male patient, 64 years of age, weighting 161.6 lb, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, movement disorder. IRINOTECAN dosage: 665 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE. Patient recovered.
Irinotecan Side Effects Report #5168776-6
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2006. Male patient, 56 years of age, weighting 323.6 lb, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain. IRINOTECAN dosage: unknown. Patient recovered.
Irinotecan Side Effects Report #5168893-0
Pharmacist from UNITED STATES reported IRINOTECAN problem on Dec 06, 2006. Male patient, 65 years of age, weighting 172.0 lb, was diagnosed with oesophageal carcinoma and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: blood pressure orthostatic abnormal, dehydration, diarrhoea, febrile neutropenia. IRINOTECAN dosage: 140 MG IV ON DAY 1, 8, 15, 22 OF 28 DAY CYCLE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5173437-3
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 08, 2006. Male patient, weighting 269.0 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: confusional state, convulsion, glioblastoma multiforme, malignant neoplasm progression, mental status changes. IRINOTECAN dosage: 325MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DILANTIN, DEPAKOTE, DECADRON, PEPCID, CLORAZEPATE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5177584-1
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Nov 28, 2006. Male patient, weighting 240.0 lb, was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, fatigue, haemoglobin decreased, immobile, red blood cell count decreased. IRINOTECAN dosage: 150 MG (150 MG), INTRAVENOUS. During the same period patient was treated with ATROPINE, ALLOPURINOL, ASPIRIN, PLAVIX, TRIAMTERENE, SIMVASTATIN, INSULIN. Patient recovered.
Irinotecan Side Effects Report #5177933-4
IRINOTECAN problem was reported by a Pharmacist from JAPAN on Nov 27, 2006. Male patient, 70 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, palpitations, productive cough. IRINOTECAN dosage: 150 MG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, FAMOTIDINE, GASMOTIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5179098-1
Health Professional from UNITED STATES reported IRINOTECAN problem on Dec 14, 2006. Male patient, weighting 136.0 lb, was diagnosed with neoplasm malignant and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, nausea, vomiting. IRINOTECAN dosage: 95 MG WEEKLY INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5192223-1
IRINOTECAN problem was reported by a Physician from JAPAN on Dec 07, 2006. Female patient was diagnosed with colon cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: mania. IRINOTECAN dosage: 100 MG. During the same period patient was treated with TEGAFUR. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5194382-3
Consumer or non-health professional from BULGARIA reported IRINOTECAN problem on Dec 19, 2006. Male patient, 20 years of age, was diagnosed with colorectal cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: hypertriglyceridaemia, peritonitis bacterial. IRINOTECAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, CALCIUM FOLINATE, BEVACIZUMAB. Patient recovered.
Irinotecan Side Effects Report #5196948-3
IRINOTECAN problem was reported by a Pharmacist from JAPAN on Dec 13, 2006. Male patient, 70 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, interstitial lung disease, palpitations, productive cough. IRINOTECAN dosage: 150 MG, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE, FAMOTIDINE, GASMOTIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5381255-6
Health Professional from JAPAN reported IRINOTECAN problem on June 25, 2007. Female patient, 57 years of age, was diagnosed with large intestine carcinoma and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, diarrhoea, stevens-johnson syndrome. IRINOTECAN dosage: DAILY DOSE:120MG. During the same period patient was treated with TEGAFUR. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5381779-1
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2007. Male patient, weighting 159.6 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: dysarthria, flushing, urinary incontinence. IRINOTECAN dosage: 325 MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, DILANTIN, DEXAMETHASONE, ATIVAN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5387017-8
Health Professional from JAPAN reported IRINOTECAN problem on July 03, 2007. Female patient, 70 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness. IRINOTECAN dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died on 06/18/2007.
Irinotecan Side Effects Report #5388566-9
IRINOTECAN problem was reported by a Health Professional from JAPAN on July 04, 2007. Female patient was diagnosed with colorectal cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, stevens-johnson syndrome. IRINOTECAN dosage: TEXT:120 MG/BODY. During the same period patient was treated with TEGAFUR. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5389557-4
Health Professional from JAPAN reported IRINOTECAN problem on July 05, 2007. Male patient, weighting 105.8 lb, was diagnosed with rectal cancer, nausea and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: gastric ulcer haemorrhage. IRINOTECAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, DECADRON, NAUZELIN, LEUCOVORIN CALCIUM, KYTRIL, GASTER, HEPARIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5400711-5
IRINOTECAN problem was reported by a Health Professional from JAPAN on July 18, 2007. Female patient was diagnosed with colorectal cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, stevens-johnson syndrome. IRINOTECAN dosage: TEXT:120 MG/BODY. During the same period patient was treated with TEGAFUR. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5401757-3
Consumer or non-health professional from JAPAN reported IRINOTECAN problem on July 19, 2007. Female patient, 47 years of age, was diagnosed with rectal cancer and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, leukopenia. IRINOTECAN dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM. Patient recovered.
Irinotecan Side Effects Report #5403922-8
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2007. Male patient, weighting 235.9 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, neutropenia. IRINOTECAN dosage: 125 MG/M2 DAY 1,8,22,29 IV. During the same period patient was treated with TEMODAR, DEXAMETHASONE, BENASEPRIL, ZANTAC, FINASTERIDE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5403924-1
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on July 31, 2007. Male patient, weighting 218.3 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: asthenia, atrial fibrillation, diarrhoea, hyperglycaemia, hypotension, neutropenia, renal failure acute, tachycardia, thrombocytopenia. IRINOTECAN dosage: 125MG/ M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, COUMADIN, LOTREL, LASIX, TOPROL, DECADRON, LIPITOR. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5403207-X
IRINOTECAN problem was reported by a Health Professional from JAPAN on July 20, 2007. Female patient, 60 years of age, was diagnosed with colon cancer recurrent and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: erythema, loss of consciousness. IRINOTECAN dosage: unknown. Patient recovered.
Irinotecan Side Effects Report #5406508-4
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Aug 01, 2007. Female patient, 56 years of age, was diagnosed with colorectal cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal infection, abdominal pain lower, acute respiratory distress syndrome, ascites, asthenia, decubitus ulcer, fatigue, fistula, hypotension. IRINOTECAN dosage: DAILY DOSE:240MG-FREQ:FREQUENCY: ONCE EVERY 2 WEEKS. During the same period patient was treated with CETUXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, PALONOSETRON, DEXAMETHASONE. Patient was hospitalized. Patient died.
Irinotecan Side Effects Report #5408844-4
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on July 30, 2007. Male patient, weighting 235.9 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, neutropenia. IRINOTECAN dosage: unknown. During the same period patient was treated with TEMODAR, DEXAMETHASONE, BENAZEPRIL HYDROCHLORIDE, ZANTAC, FINASTERIDE, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5409404-1
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Aug 08, 2007. Male patient, weighting 159.6 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: brain herniation, convulsion, haemorrhage, headache, mental status changes, nervous system disorder, posturing. IRINOTECAN dosage: 325MG/M2 DAY 1 IV. During the same period patient was treated with TEMODAR, DILANTIN KAPSEAL, DEXAMETHASONE, ATIVAN, DECADRON, PHENERGAN, MOTRIN, OXYCODONE. Patient died on 07/03/2007.
Irinotecan Side Effects Report #5409416-8
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2007. Male patient, weighting 218.3 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, atrial fibrillation, clostridial infection, dehydration, diarrhoea, hyperglycaemia, hypotension, pancytopenia, renal failure acute. IRINOTECAN dosage: 125MG/M2, 60MG/M2 DAY 1, 8 IV. During the same period patient was treated with TEMODAR, COUMADIN, LOTREL, LASIX, TOPROL, DECADRON, LIPITOR. Patient died on 08/02/2007.
Irinotecan Side Effects Report #5409417-X
Consumer or non-health professional from UNITED STATES reported IRINOTECAN problem on Aug 08, 2007. Male patient, weighting 218.3 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: aphasia, confusional state, coordination abnormal, disease progression, nervous system disorder, nuclear magnetic resonance imaging brain abnormal. IRINOTECAN dosage: 325MG/M2 DAY 1, 8 IV. During the same period patient was treated with TEMODAR, NEXIUM, DILANTIN KAPSEAL, DEXAMETHASONE, ATIVAN, AMBIEN CR. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5409600-3
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2007. Male patient, weighting 153.4 lb, was diagnosed with glioblastoma multiforme and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: confusional state, deep vein thrombosis, neutropenia, pulmonary embolism, pyrexia, sepsis, vomiting. IRINOTECAN dosage: 125MG/M2 DAY 1, 8, 22, 29 IV. During the same period patient was treated with TEMODAR, VERAPAMIL, ASPIRIN, DEXAMETHASONE, DEPAKOTE, KLONOPIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5409646-5
Pharmacist from UNITED STATES reported IRINOTECAN problem on Aug 07, 2007. Female patient, 66 years of age, was diagnosed with neoplasm malignant and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, hypovolaemia, nausea. IRINOTECAN dosage: unknown. During the same period patient was treated with LISINOPRIL, TOPROL, ZOCOR, NORVASC, HYDROCHLOROTHIAZIDE, AMBIEN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5411569-2
IRINOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2007. Female patient, 56 years of age, was diagnosed with colorectal cancer metastatic and was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: abdominal infection, abdominal pain lower, acute respiratory distress syndrome, ascites, asthenia, decubitus ulcer, fatigue, fistula, hypotension. IRINOTECAN dosage: DAILY DOSE:240MG-FREQ:FREQUENCY: ONCE EVERY 2 WEEKS. During the same period patient was treated with CETUXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, PALONOSETRON, DEXAMETHASONE. Patient was hospitalized. Patient died.
Showing 1-100 of 266 Next >
Ask Our Patient Community about Irinotecan |
||
|
|
||
|
|
||